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 Glucagon like peptide-1 (GLP-1) receptor agonists have various pharmacological 
activities, thereby which ameliorate glycemic control in patients with diabetes. 
Especially, delay of gastrointestinal transit rate is important for decreasing 
postprandial hyperglycemia. However, few studies have reported the effect of GLP-1 
receptor agonists on gastrointestinal transit time (gastric emptying time and small 
intestine transit time) in healthy dogs. In this study, we firstly examined whether 
the APAP method (evaluation of gastric emptying) and the SASP method (evaluation 
of small bowel movement) can use for evaluating gastrointestinal motility as in dogs. 
Furthermore, final objective of this study was to evaluate the influence of GLP-1 
receptor agonists on canine gastric emptying time and small intestine transit time 
using the APAP and SASP method. 
 
 We evaluated the validity of commercial APAP detection kit, measuring canine 
serum levels after the administration of APAP. Serum APAP concentrations below 5 
μg/ml were not able to evaluate accurately. Next, we evaluated the accuracy and 
reproducibility of serum APAP and SP concentration using HPLC in dogs. It would 
be better to measure the serum APAP concentration within 7 days. For investigating 
canine gastrointestinal motility, the APAP and SASP method and the Barium 
impregnated polyethylene spheres (BIPS) were compared. BIPS could not use for 
evaluating gastrointestinal motility in dogs. Next, the APAP and SASP method and 
the liquid contrast medium on canine gastrointestinal motility were compared. 
Additionally, blood metabolites were also compared. We considered that the APAP 
and SASP method is a reliable to evaluate the rate of gastric emptying and small 
intestine transit time without photographing X-ray. Finally, we investigated the 
effect of GLP-1 receptor agonists (Exenatide and liraglutide) on the gastrointestinal 
transit time and blood metabolic marker using the APAP and SASP method in 
healthy dogs. As a result, GLP-1 receptor agonists delayed gastrointestinal transit 
time. Furthermore, delayed gastrointestinal transit time induced lowering 
postprandial blood metabolic marker.  
 
 In conclusion, we established a simultaneous assay method using high performance 
liquid chromatography method of serum APAP and SP concentration in dogs. 
Additionally, we confirmed that the APAP and SASP method is a reliable to evaluate 
the gastrointestinal transit time. Furthermore, we found that the GLP-1 receptor 
agonists delayed gastrointestinal transit time in healthy dogs. These results indicate 
that the APAP and SASP method can use for monitoring the gastrointestinal motility 
in dogs and GLP-1 receptor agonists may be useful for glycemic control in diabetes 
dogs in the future. 
